Natus Medical Incorporated
Natus Medical Incorporated/ US6390501038 /
BABY
|
- -
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
-USD
|
-
|
-
Turnover: - |
-Bid Size: - |
-Ask Size: - |
1.14 bill.USD |
- |
84.51 |
Fundamentals
| |
FY 2021 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
0.39 USD |
- |
| EPS Diluted: |
0.39 USD |
- |
| Revenues per Share: |
13.76 USD |
12.13% |
| Book Value per Share: |
12.34 USD |
1.72% |
| Cash Flow per Share: |
1.86 USD |
83.01% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
473.44 USD |
13.89% |
| Net Income: |
13.18 USD |
- |
| Operating Cash Flow: |
64.00 USD |
- |
| Cash and Cash Equivalents: |
75.60 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
84.51 |
60.85 |
| P/S Ratio: |
2.40 |
1.72 |
| P/BV ratio: |
2.67 |
1.92 |
| P/CF Ratio: |
17.72 |
12.76 |
| PEG: |
- |
- |
| Earnings Yield: |
1.18% |
1.64% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
1.14 bill. USD |
816.51 mill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
34.59 mill. |
|
Profitability
| Gross Profit Margin: |
100.00% |
| EBIT Margin: |
5.02% |
| Net Profit Margin: |
2.78% |
| Return on Equity: |
3.10% |
| Return on Assets: |
2.34% |
Financial Strength
| Liquidity I / Cash Ratio: |
65.96% |
| Liquidity II / Quick Ratio: |
163.48% |
| Liquidity III / Current Ratio: |
241.96% |
| Debt / Equity Ratio: |
32.85% |
| Dynam. Debt / Equity Ratio: |
218.05% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2021-12-31 |
| Accounting Standard: |
US GAAP |
